"RPLND is an attractive option for those who prefer to avoid chemotherapy," write Jiping Zeng, MD; Timothy A. Masterson, MD; and Clint Cary, MD, MPH, MBA.
Jiping Zeng, MD
Advertisement
Articles by Jiping Zeng, MD
Advertisement
Latest Updated Articles
The role of surgery continues to evolve in seminomaSeptember 24th 2024
Advertisement
Advertisement
Trending on Urology Times
1
Gopa Iyer, MD, highlights data on anti-Nectin-4 ADC for metastatic urothelial carcinoma
2
FDA updates in urology: June 2026
3
Published VAPOR 2 data evaluate water vapor ablation for localized prostate cancer
4
Ac-225 rosopatamab tetraxetan shows promising activity in Lu-PSMA–pretreated mCRPC
5